Valeria M Borges Selected Research

Mucocutaneous Leishmaniasis

4/2016	Differential Expression of the Eicosanoid Pathway in Patients With Localized or Mucosal Cutaneous Leishmaniasis.
10/2014	Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valeria M Borges Research Topics

Disease

7	Inflammation (Inflammations) 10/2020 - 07/2002
4	Visceral Leishmaniasis (Kala Azar) 01/2017 - 01/2016
4	Cutaneous Leishmaniasis 12/2016 - 10/2014
4	Infections 01/2016 - 09/2005
3	Pneumonia (Pneumonitis) 07/2004 - 07/2002
2	Bites and Stings (Sting) 10/2020 - 01/2018
2	Leishmaniasis 01/2018 - 10/2010
2	Mucocutaneous Leishmaniasis 04/2016 - 10/2014
2	Chagas Disease (American Trypanosomiasis) 08/2015 - 02/2010
2	Diffuse Cutaneous Leishmaniasis 02/2015 - 01/2012
2	Lung Diseases (Lung Disease) 07/2004 - 06/2003
2	Fibrosis (Cirrhosis) 07/2004 - 06/2003
1	Overweight 06/2020
1	Leprosy (Hansen's Disease) 01/2017
1	Ischemic Stroke 08/2015
1	Stroke (Strokes) 08/2015
1	Parasitemia 02/2010
1	Lung Injury 10/2009
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2006

Drug/Important Bio-Agent (IBA)

3	Heme (Haem)IBA 10/2020 - 01/2016
3	CytokinesIBA 01/2012 - 10/2009
3	Fas Ligand Protein (Fas Ligand)IBA 09/2005 - 06/2003
2	Heme Oxygenase-1IBA 10/2020 - 01/2018
2	CaspasesIBA 01/2018 - 06/2003
2	Dinoprostone (PGE2)FDA Link 08/2015 - 02/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 10/2009
1	IronIBA 10/2020
1	IsoenzymesIBA 10/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2020
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	CelluloseIBA 12/2016
1	EicosanoidsIBA 04/2016
1	heme aIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 08/2015
1	ImmunosorbentsIBA 08/2015
1	PolyaminesIBA 02/2015
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 02/2015
1	ArginaseIBA 02/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2015
1	tanespimycin (17AAG)IBA 10/2014
1	PhosphatidylserinesIBA 01/2012
1	Leukocyte Elastase (Neutrophil Elastase)IBA 10/2010
1	Peroxidase (Myeloperoxidase)IBA 10/2010
1	Immunoglobulin G (IgG)IBA 02/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2006
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 06/2006
1	Lovastatin (Mevacor)FDA LinkGeneric 06/2006
1	Caspase InhibitorsIBA 07/2002
1	Silicon Dioxide (Silica)FDA LinkGeneric 07/2002

Therapy/Procedure

1	Therapeutics 01/2017
1	Drug Therapy (Chemotherapy) 12/2016